| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 27/08/24 | 07:00:12 | 27 Aug 2024 | Update on funding | RNS | |
| 22/07/24 | 07:01:00 | 22 Jul 2024 | Trading update for the year ended 30 June 2024 | RNS | |
| 22/07/24 | 07:00:10 | 22 Jul 2024 | Appointment of Nominated Adviser and Sole Broker | RNS | |
| 04/07/24 | 14:22:06 | 4 Jul 2024 | Launch of new Company Long Term Incentive Plan | RNS | |
| 27/06/24 | 07:00:14 | 27 Jun 2024 | Appointment of Non-Executive Director | RNS | |
| 10/06/24 | 07:00:07 | 10 Jun 2024 | Progression of patient cohorts in PROTECT Trial | RNS | |
| 03/06/24 | 07:00:09 | 3 Jun 2024 | Successful meetings with Paul Ehrlich Institut | RNS | |
| 31/05/24 | 07:00:13 | 31 May 2024 | Allergy Therapeutics presents findings at EAACI | RNS | |
| 07/05/24 | 07:00:15 | 7 May 2024 | Further detail from G306 Phase III field trial | RNS | |
| 03/04/24 | 07:00:10 | 3 Apr 2024 | Director Resignation | RNS | |
| 27/03/24 | 07:00:08 | 27 Mar 2024 | Update on funding | RNS | |
| 27/03/24 | 07:00:08 | 27 Mar 2024 | Interim Results for six months ended 31 Dec 2023 | RNS | |
| 12/03/24 | 08:59:47 | 12 Mar 2024 | VLP Peanut PROTECT Trial Update | RNS | |
| 12/03/24 | 07:00:10 | 12 Mar 2024 | VLP Peanut PROTECT Trial Update | RNS | |
| 11/03/24 | 07:00:06 | 11 Mar 2024 | Appointment of Shaun Furlong to Board of Directors | RNS | |
| 08/03/24 | 13:49:47 | 8 Mar 2024 | Result of AGM | RNS | |
| 14/02/24 | 07:00:04 | 14 Feb 2024 | Half-Year Trading Update 2024 | RNS | |
| 09/02/24 | 15:07:26 | 9 Feb 2024 | Notice of 2023 Annual General Meeting | RNS | |
| 30/01/24 | 07:30:00 | 30 Jan 2024 | Restoration - Allergy Therapeutics plc | RNS | |
| 30/01/24 | 07:00:08 | 30 Jan 2024 | Publication of Annual Report and Accounts 2023 | RNS | |
| 04/01/24 | 12:29:17 | 4 Jan 2024 | Total Voting Rights | RNS | |
| 02/01/24 | 07:30:00 | 2 Jan 2024 | Suspension - Allergy Therapeutics plc | RNS | |
| 27/12/23 | 12:01:20 | 27 Dec 2023 | Amendment to existing Facility Agreement | RNS | |
| 15/12/23 | 12:48:37 | 15 Dec 2023 | Annual Report and Accounts Delayed | RNS | |
| 13/12/23 | 16:54:47 | 13 Dec 2023 | PDMR dealing and Total Voting Rights | RNS | |
| 13/12/23 | 07:00:13 | 13 Dec 2023 | G306 Phase III trial meets key endpoints | RNS | |
| 11/12/23 | 07:00:09 | 11 Dec 2023 | Update on funding | RNS | |
| 01/12/23 | 07:00:08 | 1 Dec 2023 | Total Voting Rights | RNS | |
| 28/11/23 | 15:03:01 | 28 Nov 2023 | Holding(s) in Company | RNS | |
| 14/11/23 | 07:00:12 | 14 Nov 2023 | G306 Grass Phase III trial meets primary endpoint | RNS | |
| 10/11/23 | 14:39:24 | 10 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 10/11/23 | 13:22:01 | 10 Nov 2023 | Director/PCA Dealing | RNS | |
| 10/11/23 | 13:11:49 | 10 Nov 2023 | Holding(s) in Company | RNS | |
| 10/11/23 | 07:00:08 | 10 Nov 2023 | Offer Closure | RNS | |
| 09/11/23 | 10:48:33 | 9 Nov 2023 | Exercise of Options and Total Voting Rights | RNS | |
| 09/11/23 | 09:24:59 | 9 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 09/11/23 | 09:15:29 | 9 Nov 2023 | Form 8.5 (EPT/NON-RI) | RNS | |
| 08/11/23 | 10:45:56 | 8 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 07/11/23 | 11:10:16 | 7 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 06/11/23 | 09:33:31 | 6 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 06/11/23 | 07:00:14 | 6 Nov 2023 | Update on funding | RNS | |
| 03/11/23 | 09:31:44 | 3 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 02/11/23 | 10:24:05 | 2 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 01/11/23 | 10:23:22 | 1 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 31/10/23 | 08:30:21 | 31 Oct 2023 | Form 8.5 (EPT/RI) | RNS | |
| 30/10/23 | 10:06:49 | 30 Oct 2023 | Form 8.5 (EPT/RI) | RNS | |
| 27/10/23 | 11:33:16 | 27 Oct 2023 | Form 8.5 (EPT/RI) | RNS | |
| 26/10/23 | 10:07:52 | 26 Oct 2023 | Form 8.5 (EPT/RI) | RNS | |
| 25/10/23 | 09:48:58 | 25 Oct 2023 | Form 8.5 (EPT/NON-RI) | RNS | |
| 25/10/23 | 08:43:34 | 25 Oct 2023 | Form 8.5 (EPT/RI) | RNS |
| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 27/08/24 | 07:00:12 | 27 Aug 2024 | Update on funding | RNS | |
| 22/07/24 | 07:01:00 | 22 Jul 2024 | Trading update for the year ended 30 June 2024 | RNS | |
| 22/07/24 | 07:00:10 | 22 Jul 2024 | Appointment of Nominated Adviser and Sole Broker | RNS | |
| 04/07/24 | 14:22:06 | 4 Jul 2024 | Launch of new Company Long Term Incentive Plan | RNS | |
| 27/06/24 | 07:00:14 | 27 Jun 2024 | Appointment of Non-Executive Director | RNS | |
| 10/06/24 | 07:00:07 | 10 Jun 2024 | Progression of patient cohorts in PROTECT Trial | RNS | |
| 03/06/24 | 07:00:09 | 3 Jun 2024 | Successful meetings with Paul Ehrlich Institut | RNS | |
| 31/05/24 | 07:00:13 | 31 May 2024 | Allergy Therapeutics presents findings at EAACI | RNS | |
| 07/05/24 | 07:00:15 | 7 May 2024 | Further detail from G306 Phase III field trial | RNS | |
| 03/04/24 | 07:00:10 | 3 Apr 2024 | Director Resignation | RNS | |
| 27/03/24 | 07:00:08 | 27 Mar 2024 | Update on funding | RNS | |
| 27/03/24 | 07:00:08 | 27 Mar 2024 | Interim Results for six months ended 31 Dec 2023 | RNS | |
| 12/03/24 | 08:59:47 | 12 Mar 2024 | VLP Peanut PROTECT Trial Update | RNS | |
| 12/03/24 | 07:00:10 | 12 Mar 2024 | VLP Peanut PROTECT Trial Update | RNS | |
| 11/03/24 | 07:00:06 | 11 Mar 2024 | Appointment of Shaun Furlong to Board of Directors | RNS | |
| 08/03/24 | 13:49:47 | 8 Mar 2024 | Result of AGM | RNS | |
| 14/02/24 | 07:00:04 | 14 Feb 2024 | Half-Year Trading Update 2024 | RNS | |
| 09/02/24 | 15:07:26 | 9 Feb 2024 | Notice of 2023 Annual General Meeting | RNS | |
| 30/01/24 | 07:30:00 | 30 Jan 2024 | Restoration - Allergy Therapeutics plc | RNS | |
| 30/01/24 | 07:00:08 | 30 Jan 2024 | Publication of Annual Report and Accounts 2023 | RNS | |
| 04/01/24 | 12:29:17 | 4 Jan 2024 | Total Voting Rights | RNS | |
| 02/01/24 | 07:30:00 | 2 Jan 2024 | Suspension - Allergy Therapeutics plc | RNS | |
| 27/12/23 | 12:01:20 | 27 Dec 2023 | Amendment to existing Facility Agreement | RNS | |
| 15/12/23 | 12:48:37 | 15 Dec 2023 | Annual Report and Accounts Delayed | RNS | |
| 13/12/23 | 16:54:47 | 13 Dec 2023 | PDMR dealing and Total Voting Rights | RNS | |
| 13/12/23 | 07:00:13 | 13 Dec 2023 | G306 Phase III trial meets key endpoints | RNS | |
| 11/12/23 | 07:00:09 | 11 Dec 2023 | Update on funding | RNS | |
| 01/12/23 | 07:00:08 | 1 Dec 2023 | Total Voting Rights | RNS | |
| 28/11/23 | 15:03:01 | 28 Nov 2023 | Holding(s) in Company | RNS | |
| 14/11/23 | 07:00:12 | 14 Nov 2023 | G306 Grass Phase III trial meets primary endpoint | RNS | |
| 10/11/23 | 14:39:24 | 10 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 10/11/23 | 13:22:01 | 10 Nov 2023 | Director/PCA Dealing | RNS | |
| 10/11/23 | 13:11:49 | 10 Nov 2023 | Holding(s) in Company | RNS | |
| 10/11/23 | 07:00:08 | 10 Nov 2023 | Offer Closure | RNS | |
| 09/11/23 | 10:48:33 | 9 Nov 2023 | Exercise of Options and Total Voting Rights | RNS | |
| 09/11/23 | 09:24:59 | 9 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 09/11/23 | 09:15:29 | 9 Nov 2023 | Form 8.5 (EPT/NON-RI) | RNS | |
| 08/11/23 | 10:45:56 | 8 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 07/11/23 | 11:10:16 | 7 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 06/11/23 | 09:33:31 | 6 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 06/11/23 | 07:00:14 | 6 Nov 2023 | Update on funding | RNS | |
| 03/11/23 | 09:31:44 | 3 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 02/11/23 | 10:24:05 | 2 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 01/11/23 | 10:23:22 | 1 Nov 2023 | Form 8.5 (EPT/RI) | RNS | |
| 31/10/23 | 08:30:21 | 31 Oct 2023 | Form 8.5 (EPT/RI) | RNS | |
| 30/10/23 | 10:06:49 | 30 Oct 2023 | Form 8.5 (EPT/RI) | RNS | |
| 27/10/23 | 11:33:16 | 27 Oct 2023 | Form 8.5 (EPT/RI) | RNS | |
| 26/10/23 | 10:07:52 | 26 Oct 2023 | Form 8.5 (EPT/RI) | RNS | |
| 25/10/23 | 09:48:58 | 25 Oct 2023 | Form 8.5 (EPT/NON-RI) | RNS | |
| 25/10/23 | 08:43:34 | 25 Oct 2023 | Form 8.5 (EPT/RI) | RNS |
